Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease

   
   

A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulf- ate, or a salt thereof, and a second active agent comprising a phosphodiesterase-4 inhibitor for the treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.

Une composition pharmaceutique ou vétérinaire, comporte un premier agent actif choisi parmi un dehydroepiandrosterone et/ou le dehydroepiandrosterone-sulf- a mangé, ou un sel en, et un deuxième agent actif comportant un inhibiteur phosphodiesterase-4 pour le traitement de l'asthme, de la maladie pulmonaire obstructive chronique, ou d'autres maladies respiratoires. La composition est fournie dans diverses formulations et sous forme de kit. Les produits de ce brevet sont appliqués à la prophylaxie et au traitement de l'asthme, de la maladie pulmonaire obstructive chronique, ou d'autres maladies respiratoires.

 
Web www.patentalert.com

< Ligands for TGF-beta binding proteins and uses thereof

< Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

> Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient

> Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate

~ 00175